Answers are grounded in this paper and cite their sources.
Respiratory motion (RM) may affect quantitative accuracy in 18F-FDG PET for cardiac sarcoidosis (CS). Here, we evaluated the location-dependent effects of RM and RM correction (RMC) using a CS phantom with focal myocardial lesions. Methods: CS lesions were simulated by coin-shaped inserts attached to the anterior, septal, and inferior walls of a cardiac phantom. PET data were acquired under static conditions and simulated RM conditions with motion amplitudes of 10, 20, and 30 mm. RMC images were generated using data-driven respiratory gating. Both SUVmax and SUVmean were measured, and percentage changes relative to static images were calculated. Results: RM caused progressive underestimation of SUV with increasing motion amplitude. The degree of SUV reduction differed with lesion location. With motion of ±15 mm, SUVmax decreased by 44% in anterior, 39% in inferior, and 27% in septal walls. With motion correction of ±15 mm, SUVmax reductions improved to 39% in anterior, 23% in inferior, and 6% in septal walls, with the greatest improvement observed in the latter. SUVmean showed trends similar to those of SUVmax. Conclusion: RM causes a region-dependent decrease in the quantitative accuracy of 18F-FDG PET for CS lesions. Although RMC decreased SUV underestimation, a substantial underestimation remained at larger motion amplitudes. Therefore, both RM and lesion location are relevant factors to consider in quantitative PET evaluations for CS.
No takes yet. Share an insight, caveat, or question.
Onoma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: